Cancer drug nilotinib found to be safe and well-tolerated in Alzheimer's disease clinical trial

A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy.

Source link

Related posts

Study shows how specific gene variants may raise bipolar disorder risk


Pearls & Oy-sters: Rapid progression of prion disease associated with transverse myelitis: A rare presentation


The two lives of neurologist Helmut J. Bauer (1914-2008): Renowned MS specialist and National Socialist


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World